Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb dose-finding study of MP-513 added to metformin in type 2 diabetes mellitus
2008-008732-84Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of teneligliptin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Change in HbA1c from baseline to week 24. Started Apr 2009; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-008732-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008732-84.